• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
CommentaryVaccines

Trump’s former surgeon general: One year in, the war on vaccination is undoing the Trump administration’s health agenda

By
Jerome Adams
Jerome Adams
Down Arrow Button Icon
By
Jerome Adams
Jerome Adams
Down Arrow Button Icon
January 8, 2026, 2:00 PM ET

Dr. Jerome Adams served as the 20th U.S. Surgeon General during the first Trump administration (2017-21) and is a practicing anesthesiologist.

Jerome Adams
Surgeon General Jerome Adams during a Senate Health, Education, Labor, and Pensions Committee during the coronavirus pandemic on September 9, 2020, in Washington DC. Greg Nash- Pool/Getty Images

Just over a year ago, President Donald Trump nominated Robert F. Kennedy Jr. as Secretary of the Department of Health and Human Services, which sets policies and manages programs that directly affect every American.

Recommended Video

The Secretary wasted no time implementing his Make America Healthy Again agenda. One year in, it’s worth taking stock of what has worked — and what hasn’t.

There’s no question that Americans, especially children, are suffering from a chronic disease crisis. The U.S. has lower life expectancy than other developed nations, and poorer health outcomes stem at least in part from poor nutrition and environmental pollutants.

2025 delivered progress around food and nutrition. For example, food manufacturers agreed to phase out eight synthetic dyes by the end of 2026. That achievement was widely praised, as it followed years of bipartisan efforts to remove the harmful additives present in many foods Americans eat — from M&Ms and Froot Loops to even mashed potatoes.

But while the push to make our food supply healthier holds enormous promise, actions to dissuade parents from ensuring their kids get highly effective vaccines with decades-long safety records threaten to erase those gains — and more.

Nine in 10 voters want guidance from trained physicians, and 85% of Trump voters support continued vaccine innovation. Yet many of RFK Jr ‘s actions this year have directly contradicted that mandate.

In June, the Health Secretary’s “clean sweep” of the Advisory Committee on Immunization Practices (ACIP) — the independent panel responsible for delivering vaccine guidance — included firing the 17 vetted experts and replacing them with handpicked skeptics. Relying on cherry-picked numbers and anecdotes, the current members have since rescinded recommendations for some flu vaccines and changed long-standing hepatitis B vaccination guidance. And they may soon exact broader changes to the childhood schedule.

RFK Jr has also cancelled $500 million in mRNA contracts — which would have built on President Trump’s landmark achievement with Operation Warp Speed — further undermining efforts to drive breakthroughs in vaccines for cancer, Alzheimer’s, and other critical diseases.

And the Secretary has fueled the misinformation surrounding vaccine safety and guidance that has become all too common. One in three adults in 2025 reported hearing the false claim that measles vaccine is more dangerous than the virus itself. That’s up from less than 20% in 2024, and it’s sparking understandable confusion among Americans.

Of course, vaccine evaluation and monitoring should be constant, particularly for those administered to children, to ensure safety and efficacy. But the simple fact is that vaccines are among the greatest feats of modern medicine. Routine shots are expected to prevent about 508 million cases of illness and well over a million deaths among children born between 1994 and 2023.

The polio vaccine, for example, prevents paralysis in 99% of cases. It has virtually eliminated a disease that used to kill about 1,500 and paralyze 16,000 Americans every year. President Trump himself has praised it extensively.

The measles, mumps, and rubella (MMR) vaccine has subdued the most contagious virus on earth. Measles is highly infectious: In an unvaccinated population, an infected person will infect more than nine out of 10 people nearby. It can remain in the air for up to two hours after that infected person leaves an area. Before the vaccine, the virus infected over 500,000 people each year, resulting in more than 430 deaths annually.

The vaccine has kept the number of cases low, mostly hovering around 100 each year for the past few decades.

Until now.

Anti-vaccine rhetoric and policies have caused childhood vaccination rates to decrease. Since 2019, almost 80% of counties and jurisdictions across the U.S. have reported “notable declines in childhood vaccination rates.”

The drop has been most pronounced for measles. Before the pandemic, the vaccination rate among kindergartners was 95%. It has now decreased to about 92.5%. While that may not seem like a large shift, it puts the vaccination rate below the threshold needed to stop the disease from spreading.

In 2025, the U.S. recorded over 1,900 measles cases, the most in over three decades. One outbreak that began in West Texas in January killed three people, including two young girls, and infected over 860.

This month, the U.S. will almost certainly lose its measles elimination status — which it gained in 2000 thanks to widespread vaccination — after reaching a full year of continuous disease spread.  

The administration’s enthusiasm to improve America’s health has real, urgent promise. We all want to ensure kids are healthy. But this year, a course correction is essential. The country’s well-being is multi-faceted — in addition to better nutrition and exercise, it depends on access to, and evidence-based information about, the shots that have been protecting people for decades.

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune.

Join us at the Fortune Workplace Innovation Summit May 19–20, 2026, in Atlanta. The next era of workplace innovation is here—and the old playbook is being rewritten. At this exclusive, high-energy event, the world’s most innovative leaders will convene to explore how AI, humanity, and strategy converge to redefine, again, the future of work. Register now.
About the Author
By Jerome Adams
See full bioRight Arrow Button Icon

Latest in Commentary

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Commentary

heitmann
CommentaryEntrepreneurship
Here’s how to build something that lasts, from the founder of a $300 million bootstrapped company that’s been growing for 28 years straight
By Tim HeitmannMarch 1, 2026
1 day ago
world's fair
CommentaryRobots
Something big is happening in AI, but panic is the wrong reaction
By Peter CappelliFebruary 28, 2026
2 days ago
putin
CommentaryRussia
Exclusive analysis: we looked at the 400 western firms still in Russia. Their paltry size strips Putin’s bluff bare naked
By Jeffrey Sonnenfeld, Stephen Henriques, Jake Waldinger and Giuseppe ScottoFebruary 27, 2026
3 days ago
roth
CommentaryLeadership
The AI resource reallocation challenge: How can companies capture the value of time?
By Erik RothFebruary 27, 2026
3 days ago
will
CommentaryAdvertising
I’m one of America’s top pollsters and I’ve got a warning for the AI companies: customers aren’t sold on ads
By Will JohnsonFebruary 27, 2026
3 days ago
the pitt
CommentaryDEI
‘The Pitt’: a masterclass display of DEI in action 
By Robert RabenFebruary 26, 2026
4 days ago

Most Popular

placeholder alt text
Economy
Your grandparents are the reason the U.S. isn't in a recession right now. That won't last forever
By Eleanor PringleMarch 1, 2026
1 day ago
placeholder alt text
Success
MacKenzie Scott's close relationship with Toni Morrison long before Amazon put her on the path give more than $1 billion to HBCUs
By Sasha RogelbergMarch 1, 2026
18 hours ago
placeholder alt text
Middle East
As Iran attacks Dubai, the tax-free haven for the global elite could see 'catastrophic' fallout — 'this can also send shockwaves globally'
By Jason MaMarch 1, 2026
16 hours ago
placeholder alt text
Personal Finance
Trump's universal 401(k) architect on why lower-income people distrust retirement accounts: 'they want to know what the catch is'
By Jacqueline MunisFebruary 28, 2026
2 days ago
placeholder alt text
Health
Gen Z men are eating ‘boy kibble,’ the human equivalent to dog food, to load up on protein cheaply
By Jake AngeloMarch 1, 2026
21 hours ago
placeholder alt text
Middle East
U.S. military gives Iran a taste of its own medicine with cheap copycat Shahed drones, while concern shifts to munitions supply in extended conflict
By Jason MaMarch 1, 2026
14 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.